US market for Insulin Pumps is expected to grow at a CAGR of around 8.5% by 2032 | FMI

According to Future Market Insights‘ newly released Insulin Pumps Market analysis report, global sales of the Insulin Pump market in 2021 will be valued at US$ 5 billion. The projected market growth from 2022 to 2032 is 10.3%, which is significantly higher than the historical growth. Because of an aging population, an increase in diabetes incidence, and an increase in the prevalence of overweight and obesity, the absolute dollar opportunity for the Insulin Pump market is estimated to be US$ 9.7 Billion.

One of the reasons driving market expansion is an increase in the incidence of diabetes owing to age, obesity, and an unhealthy lifestyle. Obesity is a primary cause of diabetes, which leads to a rise in the prevalence of diabetes-related ocular illnesses. In 2017, the worldwide incidence of diabetes was estimated to be about 22.9 million, the prevalence was reported to be around 476 million, 1.37 million fatalities were recorded owing to diabetes, and 1.37 million disability-adjusted life-years (DALYs) were reported to be related to diabetes. According to the WHO, over 1.9 billion individuals were overweight in 2017, with around 650 million people classed as obese.

Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15803

Obesity and being overweight are risk factors that are increasing the occurrence of type II diabetes. As a result, risk factors such as smoking, being overweight, being obese, and having high cholesterol are likely to increase the prevalence of type II diabetes.

Competitive Landscape

Over the projected period, rising emphasis on innovations and investments among public and private entities is expected to strengthen competition in the market. In addition, product commercialization and partnership tactics are expected to be profitable in the upcoming years.

The key vendors in the global Insulin Pump market are Cellenovo, Sooil Development, Valeritas, Inc, JingasuDelfu Co., Ltd., Medtronic plc, Hoffmann-La Roche Ltd, Tandem Diabetic Care, Inc., Insulet Corporation, and Ypsomed.

Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-15803

Some of the recent developments in Insulin Pump market are:

• In June 2019, Medtronic announced a partnership with Tidepool to develop an interoperable automated insulin pump system. The Medtronic MiniMed pump will serve as one of Tidepool Loop’s accessories, designed to communicate with Apple devices.
• In September 2020, Insulet Corporation, stated that its Omnipod DASH Insulin Management System would be widely available in Israel, Switzerland, Austria, Germany, Belgium, and France in the coming weeks. Denmark, Norway, Finland, and Sweden have already exposure to this product.
• In June 2020, Tandem Diabetes Care and Abbott announced a collaboration to develop and commercialize integrated diabetes care solutions. These products will combine Abbott’s continuous glucose monitoring technology with Tandem’s ground-breaking insulin delivery devices to better diabetic blood sugar control.
• In September 2020, Medtronic announced that their MiniMedTM 770G hybrid closed loop system has received FDA clearance in the United States. This unique insulin administration system, which is equipped with the company’s SmartGuard technology, and can be connected to a smartphone and can be modified for youngsters as young as two years old.

Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/15803

Market Segments Covered in Insulin Pump Industry Analysis

By Type:

• Patch Pumps
• Tethered Pumps

By Product Type:

• Tandem
• Accu-Chek
• MiniMed
• Omnipod
• My Life Omnipod
• Other Product Types

By Accessories:

• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

By End-User:

• Homecare
• Hospitals & clinics
• Laboratories

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Flexible Endoscopes Market Growth – The global flexible endoscopes market is forecasted to expand at 6.4% CAGR to reach a market valuation of US$ 16.73 Billion by the end of 2033, up from US$ 8.44 Billion that was recorded for 2022.

Mobile Sterile Units Market Size – The global mobile sterile units market is projected to expand at 5.7% CAGR to reach a market valuation of US$ 391.3 Million by the end of 2033, up from US$ 214.6 Million that was recorded for 2022.

Portable Medical Devices Market Trends – The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.

Healthcare Video Conferencing Solutions Market Forecast – The market size of the Healthcare Video Conferencing Solutions Market was around US$ 87 Million in 2023 and is expected to grow with a CAGR of 5.5% from 2023 to 2033.

Specialty Medical Chairs Market Forecast – Specialty Medical Chairs Market was held at around US$ 3 Billion in 2023 and is expected to grow with a CAGR of 8.7% from 2023 to 2033.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The post US market for Insulin Pumps is expected to grow at a CAGR of around 8.5% by 2032 | FMI appeared first on Future Market Insights.